Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Marija Stepanović

3PUBLICATIONS
9CO-AUTHORS
Molecular targetsGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 02, 2021
Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells.

Ana Kostić, Sofija Jovanović Stojanov, Ana Podolski-Renić

|Jun 18, 2020
Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo.

Marija Nešović, Aleksandra Divac Rankov, Ana Podolski-Renić

|Jun 29, 2019
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-<i>d</i>]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.

Anna Lucia Fallacara, Claudio Zamperini, Ana Podolski-Renić

Pageof 1

Frequent Collaborators

3 joint publications

Milica Pešić

2 joint publications

Ana Podolski-Renić

2 joint publications

Jelena Dinić

1 joint publications

Sofija Jovanović Stojanov

1 joint publications

Miodrag Dragoj

1 joint publications

Claudio Zamperini

1 joint publications

Laura Maccari

1 joint publications

Massimo Valoti

1 joint publications

Elena Dreassi

Frequent Collaborators

3 joint publications

Milica Pešić

2 joint publications

Ana Podolski-Renić

2 joint publications

Jelena Dinić

1 joint publications

Sofija Jovanović Stojanov

Top Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:31

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on : Oct 17, 2025

79
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on : Sep 16, 2019

7.1K
<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.2K
See more related videos

Top Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:31

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on : Oct 17, 2025

79
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
09:17

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy

Published on : Sep 16, 2019

7.1K
<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.2K
See more related videos